Thao Vu and Huong Nguyen have become educational and research leaders, driven by their passion for teaching, mentorship, and scientific discovery.
While AI and robotics reshape our reality, experts explore how these emerging tools could be used to create a more equitable future – from healthcare breakthroughs to Indigenous-led innovation.
Common steroid treatments for the autoimmune disease lupus can cause as many problems as they solve, but researchers are close to finding a viable alternative.
The recent approval of a new schizophrenia drug opens the door for newer, safer, and more efficacious treatment options without the unwanted side-effects.
It’s on the rise and affects people of all body sizes and genders, but binge-eating disorder is widely misunderstood and often ignored.
A new trial is looking for chemical markers in the breath of people with silicosis. A second project will test drugs that may help lung scarring.
Antibiotics have been around for less than a century. But as resistant bacteria become increasingly difficult to treat, we risk a greater number of deaths from infections.
A new research program will target biological causes and possible treatments, including anti-psychotic drugs, brain stimulation and hormones.
On a new episode of Monash University’s “What Happens Next?” podcast, meet the healthcare providers and advocates working tirelessly to ensure that we don't lose ground in the global fight for reproductive rights.
If we get a drug for every disease and we put people on a cocktail of drugs when they're 70 years old so that they can live to 110 instead of 100, is that a good thing or not?
Professor Jamie Rossjohn is internationally recognised for using structural biology to investigate how T cells can respond to viral infections or cause autoimmunity. Now, he's been named a fellow of the oldest science academy in the world.
Antibiotic-resistant bacteria causes 700,000 deaths annually, but there are strategies we can use to slow the rapid rise of these superbugs.
Monash University is No.1 in the world for pharmacy and pharmacology, but what does that mean, and how are the university rankings calculated?
We tend to think of “psychedelics” as illegal, mind-altering substances, but they might just be the key to unlocking a revolution in mental health treatment.
The new Neuromedicines Discovery Centre (NDC) aims to develop psychiatric drugs and approaches to psychedelic-assisted psychotherapies for common mental illnesses.
Could psychedelic drugs provide the next big breakthrough in psychiatry? This episode of the ‘What Happens Next?’ podcast considers the regulatory, cultural and scientific aspects of psychedelic treatment for mental illness – and how innovation in this area could improve the lives of millions of people.
Jomo Kigotho knows from personal experience the devastating impacts of malaria. Now, the young scientist is part of a team that’s found a new weapon in the war against the disease-causing parasite.
Biotherapeutics in snake venom hold the answer to new medical treatments, and cheaper, more effective snake-bite remedies.
Researchers are delving into a protein with the potential to stop habitual drinking.
If there's ever been a time for a paradigm shift in the way we conceptualise mental health and treat mental illness, it's now.
Before COVID-19 began causing sickness, pain and death, a much bigger health threat has been evolving, and desperately needs to be stopped.
The Malaysian death penalty legal framework falls short of the fair trial standards enshrined both domestically and internationally.
Research into snake venom pivoted from Alzheimer's disease to COVID-19 when the coronavirus reared its head.
A new advocacy group aims to address gender imbalance in science by helping map the career trajectories of early-to-mid-career researchers through promotion of their existing research achievements.
Dummy text
